Summary.-Immune complexes could be isolated from sera of 7 patients with oat-cell carcinoma of the lung, but not from 5 normal controls, using zonal ultracentrifugation. After ultracentrifugation, fractions containing macromolecular IgG were absorbed on a protein A-sepharose column and the immune complexes were eluted and dissociated by glycin-HCl buffer at pH 3-5. The eluates were tested for the presence of tumour-associated proteins as carcinoembryonic antigen (CEA), nonspecific crossreacting antigen (NCA), a2 pregnancy associated antigen (a2PAG) and isoferritin. Whereas none of these tumour-associated antigens could be demonstrated, an ACTH-like activity was detected in the immune-complex fractions of 4 patients with oat-cell carcinoma, by radioimmuno-and bioassay. Polyacrylamide electrophoresis of an immune-complex fraction from a patient with Cushing syndrome showed ACTH-like activities, with mol. wt of 110,000, 75,000, 30,000 and <20,000 (all glycoproteins) indicating the presence of different subfractions of big ACTH.
SOLUBLE immune complexes detected by various methods have been described in high frequency in the circulation of patients with malignant disease (Theofilopoulos et al., 1976; Teshima et al., 1977; Gropp et al., 1979) . They are associated mainly with disseminated malignancy, especially in patients with bronchial carcinoma (Teshima et al., 1977; Gropp et al., 1979) . These findings are parallel to results obtained in animal tumour systems, showing that tumour-specific antigenantibody complexes occur in the circulation at the time of tumour spread (Sjogren et al., 1971; Baldwin et al., 1973) . Interference with cell-mediated immunity by humoral factors, such as tumour antigen, antibody or immune complexes has been well established. These studies demonstrate that tumour immunity can be suppressed by immune complexes in either a specific or nonspecific manner (Sjogren et al., 1971 , Baldwin et at., 1973 . In human cancer the identity of the antigens present in circulating immune complexes is unknown. One might speculate that the complexes contain tumour-specific antigens or tumour-associated carcinoembryonic antigens. Whereas up to now there is no evidence for tumour-specific antigens in man, a number of tumour-associated proteins, such as carcinoembryonic antigen (CEA), oai-fetoprotein (AFP), ferritin, alkaline phosphatase and several proteohormones have been associated with human malignancy (Gropp et al., 1977) .
It was the purpose of this study to isolate circulating immune complexes from sera of patients with disseminated oat-cell carcinoma of the lung and to identify the immune complex antigen(s). This tumour was investigated since large quantities of circulating complexes and some of the above-mentioned tumour-associated antigens can be detected in the serum of the patients.
MATERIALS AND METHODS
Clq-binding activity was determined with sensitized sheep erythrocytes according to Sobel et al. (1975) . The complement components C3 and C4 were detected immuno-logically by the Mancini technique (Mancini et al., 1965) topendienst West with antiserum against the C-terminal part) and biologically by measuring the serum corticosterone release in rats (weight 180 g) after injection of 0-2 ml of immune-complex fractions. Rats receiving an injection of 0-2 ml of 0.9% NaCl served as controls (Lipscomb & Nelson 1962) .
Ultracentrifugation.-80-150 ml of serum of 5 healthy blood donors and 7 patients with metastatic oat-cell carcinoma of the lung was subjected to zonal ultracentrifugation on a linear sucrose gradient (5-40% sucrose in 0-IM Tris HCI-buffer, pH 7.4) employing the Ti 15 rotor of a Spinco Beckman centrifuge (27,000 rev/min, 20 h, 4°C). After centrifugation, 10 ml fractions were collected and recorded for optical density (at 280 nm). Single fractions were tested for IgG (IgG Partigen plates, Behringwerke Marburg) by' the Mancini technique (Fig. 1 ). The fractions containing monomeric IgG and macromolecular IgG (>300,000 daltons) were pooled (pool size 200-300 ml) and absorbed to protein A-sepharose (column 30 x 5 cm, Pharmacia, Uppsala, Sweden), which specifically binds TgG via Fc receptor (Hjelm et al., 1972) . After extensive washing of the absorbed material, elution and dissociation of the bound complexes were performed by 0-iM Glycin HClbuffer, pH 3 5. The dissociated complexes eluted from protein A were dialysed against phosphate-buffered saline, pH 7-4, concentrated to 40 ml and tested for IgG, binding of Clq, complement components and tumourassociated antigens. In addition, in one patient (S.W.) the eluted material was separated again by zonal ultracentrifugation. Based on optical density, pool fractions were prepared and investigated for the different proteins described above.
Polyacrylamide-gel electrophoresis. -This was performed in the presence of sodium dodecyl sulphate (SDS) according to Weber & Osborn (1969) using 7-5% gels for nonreduced and reduced and alkylated (0-IM dithioerythrol, O-O1M iodoacetamide, Serva GmbH) samples. The gels were subjected to electrophoresis at 8 mA/gel for 5 h and stained after fixation for 1 h at 60°C with 12-5% trichloroacetic acid (TCA) with Coomassie Brilliant Blue G 250 in 7-5% acetic acid or for PAS-positive material using the periodic acid-Schiff's reagent. Three gels, run parallel, were cut in lengths of 6 mm and eluted by Veronal buffer, pH 8-4, for 24 hi. The eluates were filtered and then tested for ACTH by radioimmunoassay.
RESULTS

Tumour-associated antigens and proteins in patients' sera
In patients' sera but not in normal controls elevated levels of Clq-binding activity, of CEA, ferritin and 062 PAG were found (Table 1 ). In addition, some patients showed elevated ACTH levels using the radioimmunoassay with antisera against the C-terminal part; the test performed with the N-terminal-directed antiserum was positive only in patient S.W. (Fig. 2) . After additional ultracentrifugation, one peak was obtained from Fractions A and B, whereas Fraction C could be separated into 5 different subfractions, all reacting positively with anti-IgG, in the Clqdeviation test and in the ACTH radioimmuno-and bioassay. C4, however, could only be demonstrated in the subfractions I, IV and V. The B fraction but not the A fraction was positive for ACTH (immunologically and biologically), for IgG, for Clq-binding activity and C4.
The subfraction II of Fraction C, containing the bulk of bioactive ACTH-like activity, was subjected to polyacrylamidegel electrophoresis (Fig. 3) . After separation the gel was cut and the different fractions were eluted and tested for ACTHlike activity. In the non-reduced samples ACTH-like activities could be demonstrated in regions showing a mol. wt. of > 60,000 (PAS positive), 30,000 (PAS positive) and <20,000 (PAS positive). In the reduced samples ACTH-like activity was again present in regions of >60,000 and <20,000 daltons. The activity with 30,000 daltons disappeared. After reduction 2 protein bands with ACTH-like activity remained in the high-mol.-wt. regions (75,000 and 110,000). Simultaneously 2 strongly stained protein bands without ACTH-like activity appeared in regions with mol. wt. of about, 30,000 and 50,000. This is probably due to the reduction of IgG into heavy and light chains.
DISCUSSION
About one-third of all malignant pulmonary tumours are oat-cell carcinonmas. Thus, at least a third of the r100,000 deaths annually attributable to lung carcinoma in the United States are caused by this neoplasm, which inevitably leads to death within a short period. The presence of characteristic neurosecretorytype granules within oat-cell tumours of the lung suggests that so called K-cells (Kulchinsky cells) of the bronchial mucosa are the physiological counterpart of this tumour (Bensch et al, 1968) . Feyrter was the first to associate K-cells with an endocrine function which he considered to be part of a diffuse "endocrinic epithelial organ" (Feyrter, 1953 ). An extension of this postulate combined the K-cells with the so-called APUD (amine precursor 48 uptake and/or decarboxylation) endocrine system of polypeptide-producing endocrine, cells including those of the anterior pituitary, the parafollicular cells of the thyroid, the pancreatic islets and the gastrointestinal endocrine cells (Pearse, 1968) . In agreement with this concept is the production of ectopically synthesized hormones such as calcitonin, parathormone, antidiuretic hormone and most frequently ACTH, by oat-cell carcinoma (Whitelaw & Cohen, 1973; . Although the tumour may synthesize and secrete a form of ACTH very similar if not identical to pituitary ACTH, the predominant form of ACTH in oat-cell carcinoma extracts and of circulating ACTH in these tumour patients was big ACTH (Yalow & Berson, 1973; . Big ACTH is a precursor hormone of glycoprotein nature with different molecular entities ranging from 10,000 to >40,000 daltons. It has far less biological activity, and reacts predominantly with antisera to the C-terminal part (Orth et al., 1973) .
In this study we were able to demonstrate ACTH-like activity in immune complexes of oat-cell lung-cancer patients. These immune complexes were isolated by zonal ultracentrifugation and absorption to protein A-sepharose and contained The occurrence of the abnormal proteohormone big ACTH may be the outcome of a derepression of the genome. However, it has been speculated that the occurrence of abnormal proteohormones with high mol. wt. in patients with tumours of the endocrine system is the result of a defective degradation of a common hormone precursor into the active hormones by intracellular enzymes (Unger et al., 1964) . Autoantibody formation against big ACTH could, therefore, be the outcome of this defect in cell metabolism.
Other tumour-associated antigens were not detectable in the complexes. This is in agreement for instance with the reports showing no immunoreactivity of CEA in cancer patients (Collatz et at., 1971) . Whether autoantibody production to ACTH is common only in oat-cell carcinoma, or whether it is associated with other tumours of the APUD cell system (e.g. of the gastrointestinal tract) or whether it is a common phenomenon in human cancer has to be investigated.
Tumour immunity, and therefore the body's defence against its tumour, can be suppressed by circulating immune complexes, both specifically and nonspecifically. The occurrence of circulating immune complexes consisting of antibody and antigen formed and secreted by the tumour most frequently in patients with metastatic disease, may therefore be of some pathophysiological importance.
